Article
Mechanisms underlying methotrexate-induced pulmonary toxicity.
Expert opinion on drug safety - 1 Jul 2009
Kim Youn-Jung, Song Mee, Ryu Jae-Chun
Abstract excerpt
BACKGROUND: Methotrexate (MTX) has been widely used for the treatment of inflammatory diseases and rheumatoid arthritis, as well as a variety of tumors. However, MTX-induced pulmonary toxicity is a serious and unpredictable side effect of the therapy, which includes allergic, cytotoxic or immunologic reactions, and is a major clinical problem. OBJECTIVE: To summarize the mechanisms of action involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
